Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...

Merck MRK-1.63%decrease; red down pointing triangle KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent pipeline setbacks but raised ...

Merck KGaA’s $70 million bet on a treatment for a rare, locally aggressive cancer has delivered a phase 3 win. The ...

Life Science and Healthcare. I have been general manager for Merck Healthcare UK & Ireland since 2020. Avideh Nazeri (AN): I always dreamt of having a career that would take me around the world ...

DUBLIN--(BUSINESS WIRE)--The "European Life Science Tools and Reagents Market" report has been added to ResearchAndMarkets.com's offering. The European market for life science tools and reagents and ...

German pharma and technology giant Merck has announced a €5 million ... head of diagnostics and regulated materials at Merc Life Sciences. "This investment enables us to increase our ...

German science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a significant drop in profits in 2023. At an investment day at its headquarters ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for $600 million, it said ahead of its Capital ...

GERMAN science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for US$600 million, it said ahead of its Capital ...